Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to expose some of the factors that may be associated or predisposing to development of laryngomalacia.


Clinical Trial Description

Laryngomalacia is the most common congenital malformation of the larynx and it is a self-limited disorder. It is the most common cause of stridor in newborns and infants. It results from an abnormal prolapse of supraglottic structures during inspiration. Despite its widespread prevalence, the etiology of laryngomalacia is unclear. Most infants will squeaky but otherwise well. Although affected patients do not exhibit much in the way of other physical symptoms, the unusual voice is worrisome to their parents. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00972764
Study type Observational
Source Boushahri Clinic Medical Center
Contact
Status Completed
Phase
Start date January 2006
Completion date September 2008

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04614974 - Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia Phase 1/Phase 2
Completed NCT01165489 - Discovering Laryngomalacia N/A
Withdrawn NCT02700087 - In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms? N/A
Withdrawn NCT01782560 - Laryngomalacia Study Phase 1
Not yet recruiting NCT01991964 - The Yield of Laryngeal Ultrasound in the Diagnosis of Laryngomalacia N/A
Recruiting NCT05337475 - Feeding and Swallowing Problems in Infants With Laryngomalacia